Inflammatory cytokine gene polymorphisms in gastric cancer cases' and controls' family members from Chinese areas at high cancer prevalence

Cancer Letters

Volumn 270, Issue 2, 2008, Pages 250-259

  Feng, Yunxia ^a   Zhang, Jianzhong ^b   Dai, Liping ^a   Zhang, Jianying ^a,c   Wang, Peng ^a   Zang, Jing ^a   Li, Yuchun ^a   Wang, Kaijuan ^a,c  

^a ZHENGZHOU UNIVERSITY   (China)

^b National Institute for Communicable Disease Control and Prevention   (China)

^c UNIVERSITY OF TEXAS AT EL PASO   (United States)

Author keywords

Gastric cancer; H. pylori; Haplotype analysis; IL 1; Polymorphisms

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CHINA; CHINESE; CONTROLLED STUDY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HAPLOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IL 1 B 511 GENE; IL 1B 31 GENE; IL 1RN GENE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; STOMACH CANCER; VARIABLE NUMBER OF TANDEM REPEAT;

ADENOCARCINOMA; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; LOGISTIC MODELS; MALE; MIDDLE AGED; MINISATELLITE REPEATS; ODDS RATIO; POLYMORPHISM, GENETIC; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; STOMACH NEOPLASMS;

HELICOBACTER PYLORI;

EID: 52349087999     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.05.013     Document Type: Article

References (35)

1. Roukos D.H. Current status and future perspectives in gastric cancer management. Cancer Treat. Rev. 26 (2000) 243-255
2. Yang L., Li L.D., Chen Y.D., and Parkin D.M. Cancer Incidence and Mortality Estimates and Prediction for Year 2000 and 2005 in China. Chin. J. Health Stat. 22 (2005) 218-221
3. González C.A., Sala N., and Capella G. Genetic susceptibility and gastric cancer risk. Int. J. Cancer 100 (2002) 249-260
4. Li C., Xia H.H., Xie W., Hu Z., Ye M., Li J., Cheng H., Zhang X., and Xia B. Association between interleukin-1 gene polymorphisms and Helicobacter pylori infection in gastric carcinogenesis in a Chinese population. J. Gastroenterol. Hepatol. 22 (2007) 234-239
5. Correa P. New strategies for the prevention of gastric cancer: Helicobacter pylori and genetic susceptibility. J. Surg. Oncol. 90 (2005) 134-138
6. Suerbaum S., and Michetti P. Helicobacter pylori infection. N. Engl. J. Med. 347 (2002) 1175-1186
7. Dinarello C.A. Biologic basis for interleukine-1 in disease. Blood 87 (1996) 2095-2147
8. Zhang D., Zheng H., Zhou Y., Tang X., Yu B., and Li J. Association of IL-1 beta gene polymorphism with cachexia from locally advanced gastric cancer. BMC Cancer 7 (2007) 45
9. El-Omar E.M. The importance of interleukin 1β in Helicobacter pylori associated disease. Gut 48 (2001) 743-747
10. Vamvakopoulos J.E., Taylor C.J., Morris-Stiff G.J., Green C., and Metcalfe S. The interleukin-1 receptor antagonist gene: a single-copy variant of the intron 2 variable number tandem repeat (VNTR) polymorphism. Eur. J. Immunogenet. 29 (2002) 337-340
11. El-Omar E.M., Carrington M., Chow W.H., McColl K.E., Bream J.H., Young H.A., Herrera J., Lissowska J., Yuan C.C., Rothman N., Lanyon G., Martin M., et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404 (2000) 398-402
12. Machado J.C., Pharoah P., Sousa S., Carvalho R., Oliveira C., Figueiredo C., Amorim A., Seruca R., Caldas C., Carneiro F., and Sobrinho-Simões M. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 121 (2001) 823-829
13. Garza-González E., Bosques-Padilla F.J., El-Omar E., Hold G., Tijerina-Menchaca R., Maldonado-Garza H.J., and Pérez-Pérez G.I. Role of the polymorphic IL-1B, IL-1RN and TNF-A genes in distal gastric cancer in Mexico. Int. J. Cancer 114 (2005) 237-241
14. Lee S.G., Kim B., Choi W., Lee I., Choi J., and Song K. Lack of association between pro-inflammatory genotypes of the interleukin-1 (IL-1B-31C/and IL-1RN*2/*2) and gastric cancer/duodenalulcer in Korean population. Cytokine 21 (2003) 167-171
15. Wu M.S., Wu C.Y., Chen C.J., Lin M.T., Shun C.T., and Lin J.T. Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int. J. Cancer 104 (2003) 617-623
16. Yamada S., Matsuhisa T., Makonkawkeyoon L., Chaidatch S., Kato S., and Matsukura N. Helicobacter pylori infection in combination with the serum pepsinogen I/II ratio and interleukin-1β-511 polymorphisms are independent risk factors for gastric cancer in Thais. J. Gastroenterol. 41 (2006) 1169-1177
17. Furuta T., El-Omar E.M., Xiao F., Shirai N., Takashima M., and Sugimura H. Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenalulcer recurrence in Japan. Gastroenterology 123 (2002) 92-105
18. García-González M.A., Lanas A., Quintero E., Nicolás D., Parra-Blanco A., Strunk M., Benito R., Angel Simón M., Santolaria S., Sopeña F., Piazuelo E., Jiménez P., et al. Gastric cancer susceptibility is not linked to pro-and anti-inflammatory cytokine gene polymorphisms in whites: a nationwide multicenter study in Spain. Am. J. Gastroenterol. 102 (2007) 1192-1878
19. Zeng Z.R., Hu P.J., Hu S., Pang R.P., Chen M.H., Ng M., and Sung J.J. Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China. Gut 52 (2003) 1189-1684
20. Ruzzo A., Graziano F., Pizzagalli F., Santini D., Battistelli V., Panunzi S., Canestrari E., Catalano V., Humar B., Ficarelli R., Bearzi I., Cascinu S., et al. Interleukin1B gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter pylori-negative gastric cancer of intestinal and diffuse histotype. Ann. Oncol. 16 (2005) 887-892
21. Liao N., Duan G.C., Xi Y.L., Bai X.F., Liu C.J., and Zhao Y.X. Distribution of interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms in Henan population. China J. Dis. Control Prev. 10 (2006) 226-229
22. Wang P., Xia H.H., Zhang J.Y., Dai L.P., Xu X.Q., and Wang K.J. Association of interleukin-1 gene polymorphisms with gastric cancer: a meta-analysis. Int. J. cancer 120 (2007) 552-562
23. Y.F. Huang, The relationship among IL-1 Gene Polymorphisms, Helicobacter pylori and gastric cancer development in Fujian Province, Wanfang Digital Dissertation, 2005, p. 47.
24. Y. Zhang, Interleukin-1 polymorphisms associated with the risk of gastric carcinoma in Chinese with Helicobacter pylori infection, Wanfang Digital Dissertation, 2005, p. 41.
25. Hu S., Song Q.B., and Yu D. Association of interleukin-1 gene polymorphism with gastric cancer in a high-risk area of China. J. First Mil. Med. Univ. 24 (2004) 1171-1173
26. Al-Moundhri M.S., Al-Nabhani M., Al-Bahrani B., Burney I.A., Al-Madhani A., Ganguly S.S., Al-Yahyaee S.A., and Grant C.S. Interleukin-1β gene (IL-1B) and interleukin1 receptor antagonist gene (IL-1RN) polymorphisms and gastric cancer risk in an Omani Arab population. Gastric cancer 9 (2006) 284-290
27. Palli D., Saieva C., Luzzi I., Masala G., Topa S., Sera F., Gemma S., Zanna I., D'Errico M., Zini E., Guidotti S., Valeri A., et al. Interleukin-1 gene polymorphisms and gastric cancer risk in a high-risk Italian population. Am. J. Gastroenterol. 100 (2005) 1941-1948
28. Chen A., Li C.N., Hsu P.I., Lai K.H., Tseng H.H., Hsu P.N., Lo G.H., Lo C.C., Lin C.K., Hwang I.R., Yamaoka Y., and Chen H.C. Risks of interleukin-1 genetic polymorphisms and Helicobacter pylori infection in the development of gastric cancer. Aliment. Pharmacol. Ther. 20 (2004) 203-211
29. Rocha G.A., Guerra J.B., Rocha A.M., Saraiva I.E., da Silva D.A., de Oliveira C.A., and Queiroz D.M. IL-1RN polymorphic gene and cagA-positive status independently increase the risk of noncardia gastric carcinoma. Int. J. Cancer 115 (2005) 678-683
30. Glas J., Török H.P., and Schneider A. Allele 2 of the interleukin-1 receptor antagonist gene is associated with early gastric cancer. J. Clin. Oncol. 22 (2004) 4746-4752
31. Beales I.L. Effect of interlukin-1beta on proliferation of gastric epithelial cells in culture. BMC Gastroenterol. 5 (2002) 2-7
32. Song X., Voronov E., Dvorkin T., Fima E., Cagnano E., Benharroch D., Shendler Y., Bjorkdahl O., Segal S., Dinarello C.A., and Apte R.N. Differential effects of IL-1 alpha and IL-1 beta on tumorigenicity patterns and invasiveness. J. Immunol. 17 (2003) 6448-6456
33. Uedo N., Tatsuta M., Iishi H., Baba M., Yano H., Ishihara R., Higashino K., and Ishiguro S. Enhancement by interleukin-1 beta of gastric carcinogenesis induced by N-methyl-N0-nitro-N-nitrosoguanidine in Wistar rats: a possible mechanism for Helicobacter pylori-associated gastric carcinogenesis. Cancer Lett. 198 (2003) 161-168
34. Tamaki A., Hayashi H., Nakajima H., Takii T., Katagiri D., Miyazawa K., Hirose K., and Onozaki K. Polycyclic aromatic hydrocarbon increases mRNA level for interleukin 1 beta in human fibroblast-like synoviocyte line via aryl hydrocarbon receptor. Biol. Pharm. Bull. 27 (2004) 407-410
35. X.D. Jin, K.J. Wang, L.P. Dai, A population-based case-control Family Design Study on gastric cancer, Wanfang Digital Dissertation, 2006, p. 56.